As VP of brand strategy at Wunderman Thompson, David Brightmore spearheads strategy for some of the agency’s most important accounts, a portfolio that includes a number of oncology brands and consumer packaged goods such as Sensodyne.
After receiving an undergraduate degree in chemistry from Nottingham University followed by a graduate degree in pharmacology from Bristol University, Brightmore started his career as a medicinal chemist at AstraZeneca. While there, he gained valuable experience working in the pharma company’s cardiovascular drug discovery research and development lab. However, after some reflection he came to realize that lab work wasn’t the path for him.
And so he moved to London, taking a medical communications job at Medicom, now part of Havas, where he learned all about medical writing, advertising, public relations and public affairs. From there, Brightmore joined the account service team at Ogilvy Healthworld U.K., where he worked for two years until moving to the United States on a temporary assignment to support the merger and share best practices between Ogilvy Healthworld and CommonHealth.
In addition to his extensive industry experience and strategic vision, Brightmore is a team player who works to build up junior employees’ skills and confidence.
“David believes in leadership at all levels,” said Ryan Mazar, a former report. “He allowed me to take an active role in the account when my job description on paper was limited to administrative tasks. By taking the extra time at the early stages of my career, he helped me advance quickly.”
From the May 01, 2020 Issue of MM+M - Medical Marketing and Media
